Cargando…

Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma

BACKGROUND: High agglomeration of myeloid-derived suppressor cells (MDSCs) in neuroblastoma (NB) impeded therapeutic effects. This study aimed to investigate the role and mechanism of targeted inhibition of MDSCs by low-dose doxorubicin (DOX) to enhance immune efficacy in NB. METHODS: Bagg albino (B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei-Li, Shi, Bao-Jun, Li, Suo-Lin, Yu, Feng-Xue, Guo, Li-Na, Li, Meng, Hu, Zhi-Gang, Li, Gui-Xin, Zhou, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846436/ https://www.ncbi.nlm.nih.gov/pubmed/33278092 http://dx.doi.org/10.1097/CM9.0000000000001234

Ejemplares similares

Upregulation of CD3ζ and L‐selectin in antigen‐specific cytotoxic T lymphocytes by eliminating myeloid‐derived suppressor cells with doxorubicin to improve killing efficacy of neuroblastoma cells in vitro
por: Xu, Weili, et al.
Publicado: (2021)

ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
por: Bianchi, G, et al.
Publicado: (2014)

Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
por: Li, Yanan, et al.
Publicado: (2021)

Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
por: Yang, Zhuoshun, et al.
Publicado: (2010)

Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
por: Tian, Xinyu, et al.
Publicado: (2019)

Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
por: Frosch, Jennifer, et al.
Publicado: (2021)

Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment
por: Liang, Lifei, et al.
Publicado: (2022)

Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE(2)
por: Rong, Yuan, et al.
Publicado: (2016)

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
por: Mi, Yajing, et al.
Publicado: (2020)

Fibrinogen-like protein 2 promotes the accumulation of myeloid-derived suppressor cells in the hepatocellular carcinoma tumor microenvironment
por: Liu, Bo-Qian, et al.
Publicado: (2021)

β-carotene Regulates the Murine Liver Microenvironment of a Metastatic Neuroblastoma
por: Lim, Ji Ye, et al.
Publicado: (2013)

Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
por: Tumino, Nicola, et al.
Publicado: (2021)

Myeloid-derived suppressor cells and pulmonary hypertension
por: Zhang, Hui, et al.
Publicado: (2023)

Doxorubicin treatment induces tumor cell death followed by immunomodulation in a murine neuroblastoma model
por: INOUE, SEIICHIRO, et al.
Publicado: (2014)

IL-12 Enhances Immune Response by Modulation of Myeloid Derived Suppressor Cells in Tumor Microenvironment
por: Choi, Ji-Na, et al.
Publicado: (2019)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products
por: Calderon, Jhon Jairo, et al.
Publicado: (2023)

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer
por: Khan, Anm Nazmul H., et al.
Publicado: (2015)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy
por: Li, Xueyan, et al.
Publicado: (2021)

Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
por: Jin, Shuiling, et al.
Publicado: (2020)

Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells
por: Lian, Min, et al.
Publicado: (2019)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012)

Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment
por: Li, Haoyu, et al.
Publicado: (2016)

MicroRNA-141-5p Acts as a Tumor Suppressor via Targeting RAB32 in Chronic Myeloid Leukemia
por: Bao, Jing, et al.
Publicado: (2020)

Artificial Tumor Microenvironments in Neuroblastoma
por: Quinn, Colin H., et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
por: Wang, Ying, et al.
Publicado: (2021)

The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells
por: Giannotta, Claudia, et al.
Publicado: (2023)

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
por: Hao, Zhaonian, et al.
Publicado: (2021)

Anti-Cancer Effect of HIV-1 Viral Protein R on Doxorubicin Resistant Neuroblastoma
por: Zhao, Richard Y., et al.
Publicado: (2010)

Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
por: He, Zhong-Ning, et al.
Publicado: (2023)

Rgs2 Mediates Pro-Angiogenic Function of Myeloid Derived Suppressor Cells in the Tumor Microenvironment via Upregulation of MCP-1
por: Boelte, Kimberly C., et al.
Publicado: (2011)

Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer
por: Aliper, Alexander M., et al.
Publicado: (2014)

FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
por: Li, Dan, et al.
Publicado: (2013)

The role of myeloid‐derived suppressor cells in gastrointestinal cancer
por: Cui, Cheng, et al.
Publicado: (2021)

Targeting myeloid-derived suppressor cells for cancer therapy
por: Tang, Hongchao, et al.
Publicado: (2021)

New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy
por: Guo, Gang, et al.
Publicado: (2015)

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
por: Corzo, Cesar A., et al.
Publicado: (2010)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fp798id7b9e1nvpgjnk70uuuna